Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer
Thierry Bury, Afshin Dowlati, Pascal Paulus et al. · European Respiratory Journal · 1997
Despite advances in morphological imaging, some patients with lung cancer are found to have nonresectable disease at surgery or die of recurrence within yr of surgery. We performed a prospective study in 109 patients to compare the accuracy of whole-body positron emission tomography (PET) using fluorine-18 deoxyglucose (18FDG) and conventional imaging (CI) methods for the staging of non-small cell lung cancer (NSCLC). When CI or PET study suggested metastatic disease, confirmation was obtained by biopsy or follow-up information. As compared to CI, 18FDG-PET correctly changed the N stage in 22 patients (33%) and the M stage in 15 patients (14%). For the detection of distant metastases, PET study showed five false-positive sites and no false-negative cases. Currently, the accuracy of PET in the detection of M stage is 96%. Our study shows that visual interpretation of whole-body fluorine-18 deoxyglucose-positron emission tomography images can improve the diagnostic accuracy in the staging of non-small cell lung cancer. Further experience is needed to establish if metabolic imaging would be a cost-effective tool in the future management of lung cancer.
Cited by 160 works. doi:10.1183/09031936.97.10112529 Open-access PDF
Authors
References
- Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling.
- Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation.
- CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group.
- Transport of sugars in tumor cell membranes
- Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling.
- Staging non—small cell lung cancer by whole-body positron emission tomographic imaging
- Mediastinal lymph node staging of non-small-cell lung cancer: A prospective comparison of computed tomography and positron emission tomography
- Fluorodeoxyglucose-Positron Emission Tomography in the Detection and Staging of Lung Cancer
- Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma.
- Mediastinal Staging of Non-Small-Cell Lung Cancer With Positron Emission Tomography